Atlas Trials

Hepatic Impairment Trial of Obeticholic Acid

Clinical trial NCT01904539 · COMPLETED

Trial details

NCT number
NCT01904539
Sponsor
Intercept Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2013-06-01
Primary completion
2013-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.